VNRX: VolitionRx Reports 2023 Results; Distribution of Nu.Q Vet Test Expanding; Nu.Q Discover Growing; Two Key R&D Efforts in 2024/25: 1) Breakthrough Cancer Detection Method (Capture -PCR...
VolitionRX Limited (VNRX)
NASDAQ:AMEX Investor Relations:
ir.volitionrx.com
Company Research
Source: Yahoo! Finance
Commercialization of Nu.Q Vet Continues During 2023, Volition Veterinary (NYSE:VNRX) continued to expand its distribution network through new supply agreements. The Nu.Q Vet Cancer Test is currently available in • the U.S. (initial product launch in November 2020 through direct sales being processed at the GI Lab at Texas A&M University followed by IDEXX in January 2023), • the U.K. & Ireland (launched in the U.K. and Ireland through the Veterinary Pathology Group, and in the U.K. through Nationwide Laboratories, both November 2023), • Portugal (DNAtech - product launch in November 2022), • Singapore (SAGE Healthcare), • Taiwan (Vita Genomics - product launch in November 2023) and • Italy (scil animal care company GmbH, an Antech company). A recent incremental supply agreement for Japan (Fujifilm Vet Systems) was just signed in March 2024. During 2023, Nu.Q Vet Cancer Screening Tests generated revenues of approximately on the sales of over 58,000 tests. In 2024, N
Show less
Read more
Impact Snapshot
Event Time:
VNRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VNRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VNRX alerts
High impacting VolitionRX Limited news events
Weekly update
A roundup of the hottest topics
VNRX
News
- VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through Antech [Yahoo! Finance]Yahoo! Finance
- Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through AntechPR Newswire
- Antech's breakthrough cancer screening tool launches in Europe, supporting early canine cancer detection [Yahoo! Finance]Yahoo! Finance
- VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
VNRX
Earnings
- 11/14/23 - Beat
VNRX
Sec Filings
- 4/26/24 - Form PRE
- 4/26/24 - Form 8-K
- 3/26/24 - Form D
- VNRX's page on the SEC website